Drug
Fibrogammin P
Fibrogammin P: highest development phase Phase 2, developed by CSL. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- CSL
Trials
| Drug | Phase | Indication |
|---|---|---|
| Fibrogammin®P, coagulation factor XIII concentrate (Human) NCT02551042 | Phase 2 | Systemic Sclerosis |
Latest
No recent events.
Follow Fibrogammin P on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.